Addition of FFRct in the Diagnostic Pathway of Patients With Stable Chest Pain

Recruiting N/A Interventional Study
Chest Pain Epicardial Plaques
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
528 (estimated)
Sponsor
Erasmus Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Rationale: Patients with stable chest pain enter a diagnostic pathway where Coronary Computed Tomography Angiography (CCTA) is often the first line non-invasive test to detect coronary stenosis. An anatomically significant (≥ 50% luminal narrowing) stenosis on CCTA does however not always cause cardiac ischemia (i.e. hemodynamically significant stenosis). CCTA is often followed by invasive coronar…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Stable chest pain and the patient underwent CCTA which demonstrated ≥50% but less than 90% stenosis in any major epicardial vessel with a diameter ≥ 2 mm. Exclusion Criteria: * Inability to provide informed consent * Unstable angina according to ESC guidelin…
Contacts

Simran Sharma, MD

+317030420

s.sharma@erasmusmc.nl

CONTACT

Laurens Groenendijk

+31107033612

l.groenendijk@erasmusmc.nl

CONTACT